Call for Papers

Cellular & Molecular Bioengineering Special Issue on ‘Emerging Technologies for Use in the Study, Diagnosis and Treatment of Patients with COVID-19’

COVID-19 is predicted to overwhelm healthcare capacity in the US and worldwide. The cellular and molecular bioengineering community has a history of innovative approaches to address pressing biomedical challenges. As a voice for the this community, the journal Cellular & Molecular Bioengineering (CAMB) welcomes commentaries, reviews, and original research articles that reflect the ways in which we continue to contribute to fields that have become central to understanding, treating, and managing the COVID-19 pandemic. Some examples include:

• On-a-chip platforms for diagnostics, drug screening, toxicology, and basic research;
• Innovative approaches to reduce cytokine “storms”;
• Technologies to understand, diagnose, and treat cardiovascular and other COVID-19 comorbidities;
• Understanding sensory function of taste and smell;
• Platforms to understand, diagnose, and treat zoonoses;
• Commentary from trainees, faculty, and administrators.

A team of physician-scientists have volunteered to help refine and provide constructive feedback to encourage contributors who may not be content experts in virology or patient care. These articles will be free for download at CAMB thanks to the generous support of publisher Springer Nature.

Timeline:

1. May 15^th - Submission of Letters of Intent (LOI) to guest editors

a. Include article name and type, author list, and a brief summary (<250 words) of content/topic

b. Further details on the format of articles for CAMB can be found here: https://www.springer.com/journal/12195/

2. May 29^th - Submission of Manuscript to guest editors

a. Papers will be reviewed in 7-10 days following receipt

Guest Editors:

· Owen McCarty, PhD, FAHA, Oregon Health & Science University: mccartyo@ohsu.edu

· Chelsey Simmons, PhD, University of Florida: css@ufl.edu

· Anubhav Tripathi, PhD, Brown University: anubhav_tripathi@brown.edu

Advisory Group of Clinician-Scientists:

· Sven Olson, MD, Oregon Health & Science University

· Vikram Raghunathan, Oregon Health & Science University

· Brent Savoie, MD, JD, Vanderbilt University Medical Center

· Joseph Shaztel, MD, Oregon Health & Science University

· Derrick Tao, MD, Oregon Health & Science University

Cellular and Molecular Bioengineering (CMBE) focuses on research that studies how cellular behavior arises from molecular-level interactions to tackle the challenge of improving human health. It offers investigators a forum for the dissemination of research that utilizes engineering principles and methods to advance fundamental knowledge and technological solutions related to cellular and molecular systems. Specific cell processes of interest include cell growth, differentiation, migration, signal transduction, protein secretion and transport, gene expression and regulation, and cell-matrix interactions.

CMBE is an official journal of the Biomedical Engineering Society (BMES).

General Details on the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online and Print Color Images
- Optional Open Access Publication Fee (APC) – USD 3260,- / Euro 2570,- / GBP 2160,-

• Studies how cellular behavior arises from molecular-level interactions to tackle the challenge of improving human health
• Covers many cell processes of interest, including cell growth, differentiation, migration, signal transduction, protein secretion and transport, gene expression and regulation, and cell-matrix interactions
• Journal of the Biomedical Engineering Society (BMES)